NCT04842123 - Electrocardiogram Clinical Validation Study | Biotech Hunter

Enrollment

568

Participants

Timeline

Start Date

March 31, 2021

Primary Completion Date

October 4, 2021

Study Completion Date

October 4, 2021

Conditions

Atrial Fibrillation

Interventions

DIAGNOSTIC_TEST

Electrocardiogram

Simultaneous assessment of the heart rhythm determined from a 12-lead ECG and the Garmin ECG software algorithm heart rhythm classification on single-lead ECG data derived from the wearable device. All participants will record three simultaneous 12-lead and single-lead ECGs.

Trial Locations (6)

10075

Northwell Health Lenox Hill Hospital, New York

11030

Northwell Health North Shore University Hospital, Manhasset

20010

MedStar Washington Hospital Center, Washington D.C.

22031

MedStar Health Cardiac Electrophysiology at Fairfax, Fairfax

55102

HealthEast, Saint Paul

85018

Hope Research Institute, Phoenix